High urgency

Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment

Detected July 5, 2026 · in Telehealth Cross-State Licensing

The DEA final rule implements the SUPPORT Act, allowing telehealth prescribing of controlled substances for medication-assisted treatment (MAT) without an initial in-person visit, but with new registration and recordkeeping requirements.

Aforeworn detected this change in the Telehealth Cross-State Licensing space on July 5, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Telehealth platforms, virtual specialty clinics, behavioral-health providers, e-prescribers should confirm how it applies to their specific situation before acting. There is a time constraint attached: Effective 30 days after publication (July 9, 2026); registration applications open now.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Telehealth Cross-State Licensing continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.

What changed

DEA now permits telehealth prescribing of buprenorphine and other controlled substances for MAT without an initial in-person exam, but requires a special registration, patient limits, and compliance with state laws.

Who it affects

Telehealth platforms, virtual specialty clinics, behavioral-health providers, e-prescribers

What you must do

Obtain DEA special registration for telehealth prescribing of controlled substances for MAT; update protocols to include patient limits and recordkeeping.

Deadline

Effective 30 days after publication (July 9, 2026); registration applications open now.

Source: https://www.federalregister.gov/documents/2026/06/09/2026-11526/implementation-of-the-substance-use-disorder-prevention-that-promotes-opioid-recovery-and-treatment

Never miss a change like this again

Aforeworn watches Telehealth Cross-State Licensing around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.

Start your free trial

Related changes in Telehealth Cross-State Licensing